Monday, November 25, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
Superbug News - CoronaVirus Watch List

Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.

Editor / Curator -
Aphex BioCleanse
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.

Editor / Curator -
Stand Down.

Stand Down VII: Could We Have a Down 20% Day?

Editor / Curator -
Superbug News - CoronaVirus Watch List

Telehealth DTC Startup Ro is now Offering Coronavirus Assessments (ModernRetail).

Editor / Curator -
coronavirus stocks
Superbug News - CoronaVirus Watch List

Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Coronavirus Stocks Still on a Tear.

Editor / Curator -
Draganfly
AI Artificial Intelligence

Draganfly (DFLYF) Closes $15 Million Reg A Offering.

Editor / Curator -
video
Video

What is Bacteria? Structure & Types, Prof. Dr. Vincent Racaniello (Lecturio).

Editor / Curator -
hAPBEE, bIOTECH sTOCK rEVIEW
All News

Whitepaper: Effects of Magnetic Fields on Biological Systems

Editor / Curator -
Biotech News

Stand Down VI: Dow 10,000? It Could Happen.

Editor / Curator -
1...707172...93Page 71 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.